Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jan Kikec"'
Autor:
Sebastian Barth, Martina B. Hautmann, Christian Muñoz Pérez, Sebastian Kerber, Jan Kikec, Michael Zacher, Borek Foldyna, Lukas Lehmkuhl, Philipp Halbfass, Ulrich Lüsebrink, Karsten Hamm
Publikováno v:
Hellenic Journal of Cardiology, Vol 65, Iss , Pp 8-14 (2022)
Objectives: The PASCAL device is a transcatheter edge-to-edge repair system (TEER) for treatment of mitral regurgitation (MR). The PASCAL Ace as a newer version of the PASCAL device consists of a thinner profile without a spacer. The aim of the study
Externí odkaz:
https://doaj.org/article/38839641545c4d60946154067a12fd90
Autor:
Christian Waechter, Felix Ausbuettel, Georgios Chatzis, Juan Cheko, Dieter Fischer, Holger Nef, Sebastian Barth, Philipp Halbfass, Thomas Deneke, Sebastian Kerber, Jan Kikec, Hans-Helge Mueller, Dimitar Divchev, Bernhard Schieffer, Ulrich Luesebrink
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 21, p 5044 (2021)
Atrial fibrillation (AF) is a highly prevalent comorbidity in patients with severe mitral valve regurgitation (MR) undergoing transcatheter mitral valve repair (TMVR) and has been shown to significantly worsen their outcome. However, data on the impa
Externí odkaz:
https://doaj.org/article/2cb3503d16ed4f21acb11dbb36857d1a
Autor:
Georgios Chatzis, Sebastian Kerber, Sebastian Barth, Ulrich Luesebrink, Jan Kikec, Felix Ausbuettel, Holger Nef, Dimitar Divchev, Hans-Helge Mueller, Juan Cheko, Bernhard Schieffer, Philipp Halbfass, Christian Waechter, Dieter Fischer, Thomas Deneke
Publikováno v:
Journal of Clinical Medicine
Volume 10
Issue 21
Journal of Clinical Medicine, Vol 10, Iss 5044, p 5044 (2021)
Volume 10
Issue 21
Journal of Clinical Medicine, Vol 10, Iss 5044, p 5044 (2021)
Atrial fibrillation (AF) is a highly prevalent comorbidity in patients with severe mitral valve regurgitation (MR) undergoing transcatheter mitral valve repair (TMVR) and has been shown to significantly worsen their outcome. However, data on the impa
Autor:
Alaa Shalla, Sebastian Barth, Martina B. Hautmann, Borek Foldyna, Philipp Halbfass, Michael Zacher, Lukas Lehmkuhl, Sebastian Kerber, Ulrich Lüsebrink, Jan Kikec, Wilko Reents
Publikováno v:
Journal of cardiology. 78(6)
Background: The PASCAL system (Edwards Lifescience, Irvine, CA, USA) is a novel device for edge-to-edge treatment of mitral regurgitation (MR). The aim of our study was to examine the functional and hemodynamic outcome after repair of functional (FMR
Autor:
Michael Zacher, Karsten Hamm, Patrick Ranosch, Martina B. Hautmann, Borek Foldyna, Ulrich Lüsebrink, Lukas Lehmkuhl, Eleni Arvaniti, Sebastian Barth, Philipp Halbfass, Sebastian Kerber, Jan Kikec
Publikováno v:
Clinical research in cardiology : official journal of the German Cardiac Society. 110(5)
To examine the functional and hemodynamic mid-term outcome at 5 months of mitral regurgitation (MR) reduction using the PASCAL repair system. Between July 2019 and February 2020 31 consecutive patients with MR 3 +/4 + (mean age 77.5 years, all in New